In-Vitro Toxicology Testing Market Size, Share & Industry Analysis, By Product Type (Equipment, Assay kits, Consumables, Software, Others), By Technology (PCR Technology, Western Blot, Cell Culture Technology, Imaging Technology, Screening Technology, Others), By Applications (Neuro Toxicity, Dermal Toxicity, Cytotoxicity, Others) and Regional Forecast, 2024-2032

Toxicology deals with the study of biological organisms being harmed by the chemical substances. In-vitro toxicology testing is defined as the cultured bacteria being affected by the chemical substances. These methods are carried to identify dangerous chemicals to confirm the lack of assured contaminated properties in the initial stages of the growth of new substances which include food additives, therapeutic drugs, and agricultural chemicals. This test is majorly done to evaluate drug development safety and for chemical, based on their strength. Additionally, the main advantage of the in-vitro test system is assessment for the screening of drugs, chemicals, pesticides, toxicants, and others. Various technologies are used for in-vitro testing which includes toxic genomics, molecular imaging techniques, genomics, cell-cultured technology, and among others that are propelling the growth of the market during the forecast period.

Major driving factors of the in-vitro toxicology testing market are rise in check of drug safety, rise in safety of consumer product, rise in ranking and screening of potential drugs, increase in number of in-vitro tests being performed, and others. Application such as Cytotoxicity testing can be used for pharmaceuticals drug testing by screening technology before the use of any other toxicology testing. In addition to this, cytotoxicity testing is used for quality control testing of manufactured drug. In-vitro toxicology majorly helps in chemical safety assessment, which is also propelling the growth of the market. Moreover, opposition to animal testing, rise in investment in research and development activities by manufacturers to develop their product portfolio, etc. are triggering the growth of the market. Various applications such as derma toxicity, cytotoxicity, and others are also influencing the growth of the market. Also, early stages of drug safety detection are boosting the growth of the market. Rise in focus towards drug discovery and personalized medicine by using in-vitro drugs are emerging as the potential opportunities for the market growth.

However, lack of professionals, stringent regulation by regulatory bodies for considering alternative methods for safety check, etc. are hindering the growth of the market during the forecast period.

Market Segmentation:

Globally, the in-Vitro Toxicology Testing market is segmented on basis of product type, technology, application, end users, and region. Based on the product type, the market is segmented into equipment, assay kits, consumables, software, and others. Based on applications, the market is classified into neuro toxicity, dermal toxicity, cytotoxicity, and others. Based on technology, the market is segmented into PCR technology, Western blot, cell culture technology, imaging technology, and others. Based on the end users, the market is classified into pharmaceutical industries, biotechnological industries, academic and research centers, and others.

Geographically, the In-Vitro Toxicology Testing market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

The major companies in the global In-Vitro Toxicology Testing Market include Thermo Fisher Scientific Inc., Merck KGaA, Covance, Inc., Bio-Rad Laboratories, Inc., Gentronix, Creative Biolabs, GE Healthcare, Qiagen N.V., and others.

Key Insights:

• New Product Launches


• Key Industry Developments


• Pricing Analysis

Regional Analysis:

Geographically, the global in-vitro toxicology testing market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America is dominating the market owing technological advancements, huge investment in the healthcare industry, drug safety checking, and the quick adoption of technology.

Europe is the second-largest contributor to the market owing to an increase in healthcare awareness related blood reaction and donation, increased per-capita income & expenditure, and improved healthcare infrastructure. Asia Pacific is anticipated to experience vast growth in the market owing to rise in geriatric population, an increase in healthcare awareness, and an increase in government initiatives towards the healthcare sector, and an increase in the number of research activities. Latin America and Middle East & Africa are also anticipated to experience lucrative growth in the market.

Segmentation

In-Vitro Toxicology Testing Industry Developments

• In 0ctober 2018, SGS SA launched the new in-vitro testing which consists of development of present cell/tissue culture capabilities, flow cytometry and mass spectrometry facilities, along with the introduction of high throughput screening, automation, and multiplexing technologies